Skip to main content
. 2021 Jun 9;12:645180. doi: 10.3389/fmicb.2021.645180

TABLE 3.

S. aureus FBEC index values.

MBEC for 2CP (alone) (μg/ml) MBEC for 2CP (combined) (μg/ml) MBEC for antibiotic (alone) (μg/ml) MBEC for antibiotic (combined) (μg/ml) FBEC Interpretation
S. aureus
Tobramycin 1,000 31.25 2.5 1.25 0.531 Additive
Tetracycline 1,000 125 1.25 0.625 0.625 Additive
Levofloxacin 1,000 250 1 0.25 0.5 Synergistic

MBEC for C2DA (alone) (μg/ml) MBEC for C2DA (combined) (μg/ml) MBEC for antibiotic (alone) (μg/ml) MBEC for antibiotic (combined) (μg/ml) FBEC Interpretation

Tobramycin 1,000 125 2.5 1.25 0.625 Additive
Tetracycline 1,000 500 1 0.25 0.75 Additive
Levofloxacin 1,000 125 1 0.25 0.375 Synergistic

MBEC for T2DA (alone) (μg/ml) MBEC for T2DA (combined) (μg/ml) MBEC for antibiotic (alone) (μg/ml) MBEC for antibiotic (combined) (μg/ml) FBEC Interpretation

Tobramycin 1,000 125 2.5 1.25 0.625 Additive
Tetracycline 1,000 500 1 0.25 0.75 Additive
Levofloxacin 1,000 500 1 0.25 0.75 Additive

Minimum biofilm eradication concentration (MBEC) for 2CP, C2DA, and T2DA against S. aureus biofilm when treated alone or combined with tobramycin, tetracycline, or levofloxacin. MBEC of each antibiotic against S. aureus alone is also included. These values were used in Equation 2 to determine the fractional inhibitory concentration index for each fatty acid/antibiotic combination. FBEC index values less than or equal to 0.5 indicate synergy, values between 0.5 and 1 indicate additivity, values between 1 and 2 indicate indifference, and values above 2 indicate antagonism.